Neurochem Int 128:94105 Davies M, Faerch L, Jeppesen OK, Pakseresht A, Pedersen SD, Perreault L et al (2021) Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
Journal of Cosmetic Dermatology (2025 Jan;24(1)) Efficacy and safety of high-intensity, high-frequency, non-focused ultrasound parallel beams for facial skin laxity, Gold MH, Biron J
Medicare and most Medicaid programs currently exclude weight loss drugs altogether, though some may cover them when prescribed for type 2 diabetes
Similarly, at week 52, the improvement in PFWD was also consistent in the semaglutide group vs placebo in both sexes (Figure 3)
Thats where QuickMD comes in
Stay Aggressively Hydrated Diarrhea depletes fluids faster than you realize